TAT and infection: Furthermore, other naturally occurring polymorphisms within Tat identified in HIV-infected patients at acute and/or early infection phase (i.e., P10S, W11R, K19R, A42V, and Y47H) have been shown to significantly impair transactivation activity in the infected CD4+ T lymphocytes [77].